BPC 157

BPC 157 Peptide: Comprehensive Research Guide

Body Protection Compound 157, commonly known as BPC 157, is a synthetic peptide derived from a protein found in human gastric juice. This 15-amino-acid peptide has gained significant attention in the research community due to its remarkable healing properties and wide range of potential therapeutic applications. Researchers worldwide are investigating BPC 157 for its ability to accelerate wound healing, protect organs, reduce inflammation, and promote tissue regeneration.

At Hanpro Peptides, we provide the highest purity BPC 157 for research purposes only. Our products are manufactured in state-of-the-art facilities and undergo rigorous quality testing to ensure 99%+ purity. This comprehensive guide covers everything researchers need to know about BPC 157, including its molecular structure, mechanisms of action, research applications, proper handling, and frequently asked questions.

Molecular Structure and Properties

BPC 157 is a pentadecapeptide consisting of 15 amino acids with the sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its molecular formula is C₆₂H₉₈N₁₆O₂₂, with a molecular weight of approximately 1419.5 g/mol. The peptide is highly stable and soluble in water, making it suitable for various research applications.

The sequence of BPC 157 was originally identified from a protective protein found in gastric juice. Researchers discovered that this specific 15-amino-acid fragment retained most of the parent protein’s healing properties while offering improved stability and bioavailability. The peptide’s unique structure allows it to interact with multiple biological pathways, contributing to its diverse range of effects.

Mechanisms of Action

BPC 157 exerts its effects through multiple interconnected mechanisms, making it a versatile research compound. Understanding these mechanisms is crucial for designing effective research studies and interpreting results.

1. Growth Factor Modulation: BPC 157 has been shown to upregulate the expression of various growth factors, including vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and fibroblast growth factor (FGF). These growth factors play essential roles in angiogenesis, collagen synthesis, and tissue regeneration.

2. Angiogenesis Promotion: One of the key mechanisms of BPC 157 is its ability to promote the formation of new blood vessels (angiogenesis). This process is critical for delivering oxygen and nutrients to injured tissues, facilitating the healing process. Research has demonstrated that BPC 157 can stimulate endothelial cell proliferation and migration, leading to improved blood flow to damaged areas.

3. Anti-Inflammatory Effects: BPC 157 exhibits potent anti-inflammatory properties by modulating the production of inflammatory cytokines. It has been shown to reduce levels of pro-inflammatory markers such as TNF-α, IL-1β, and IL-6 while increasing anti-inflammatory cytokines. This dual action helps create a more favorable environment for healing.

4. Collagen Synthesis and Tissue Remodeling: BPC 157 stimulates fibroblasts to produce collagen and other extracellular matrix components. This is essential for strengthening repaired tissues and preventing re-injury. The peptide also promotes the organized deposition of collagen fibers, resulting in stronger, more functional scar tissue.

5. Nitric Oxide Pathway Interaction: BPC 157 interacts with the nitric oxide (NO) system, which plays a crucial role in vasodilation, blood flow regulation, and wound healing. By modulating NO production, BPC 157 can improve circulation to injured areas and support the healing process.

Research Applications

BPC 157 has been investigated in numerous preclinical studies for its potential therapeutic applications across various medical fields. The following sections highlight the most promising areas of research.

1. Musculoskeletal Injury Repair

One of the most extensively studied applications of BPC 157 is in the repair of musculoskeletal injuries, including tendon, ligament, muscle, and bone damage. Preclinical studies have demonstrated that BPC 157 can significantly accelerate the healing of tendon and ligament injuries by promoting collagen synthesis, angiogenesis, and fibroblast proliferation at the injury site.

In animal models of Achilles tendon injury, BPC 157 treatment resulted in faster healing, improved tensile strength, and better组织结构 compared to controls. Similarly, studies on ligament injuries showed enhanced collagen fiber organization and increased mechanical strength in treated groups. For muscle injuries, BPC 157 has been shown to reduce scar tissue formation and promote the regeneration of functional muscle fibers.

Bone healing is another area where BPC 157 shows promise. Research indicates that BPC 157 can stimulate osteoblast activity and bone mineralization, leading to faster fracture healing. In animal models of bone defects, BPC 157 treatment resulted in increased bone volume, improved bone density, and enhanced biomechanical properties of the repaired bone.

2. Gastrointestinal Protection and Healing

Given its origin from gastric juice, it is not surprising that BPC 157 has been extensively studied for its gastrointestinal protective effects. The peptide has been shown to protect against various forms of gastrointestinal damage, including ulcers induced by NSAIDs, alcohol, stress, and Helicobacter pylori infection.

In animal models of gastric ulcers, BPC 157 treatment significantly reduced ulcer size, promoted mucosal healing, and restored the integrity of the gastric lining. The peptide’s protective effects are attributed to its ability to stimulate mucus production, enhance blood flow to the gastric mucosa, and promote the proliferation of epithelial cells.

BPC 157 has also shown promise in treating inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. In animal models of colitis, BPC 157 treatment reduced intestinal inflammation, preserved mucosal integrity, and improved clinical symptoms. The peptide’s anti-inflammatory properties, combined with its ability to promote tissue repair, make it a promising candidate for further investigation in IBD research.

Additionally, BPC 157 has been studied for its potential to heal fistulas, which are abnormal connections between organs that can occur in conditions like Crohn’s disease. Preliminary research suggests that BPC 157 may promote the closure of fistulas by stimulating tissue regeneration and reducing inflammation at the fistula site.

3. Cardiovascular Protection

BPC 157 has demonstrated significant cardiovascular protective effects in various preclinical studies. The peptide has been shown to protect against heart damage caused by ischemia-reperfusion injury, which occurs when blood supply returns to the heart after a period of deprivation.

In animal models of myocardial infarction, BPC 157 treatment reduced infarct size, preserved cardiac function, and improved survival rates. The peptide’s cardioprotective effects are attributed to its ability to reduce oxidative stress, inhibit apoptosis (programmed cell death) of cardiomyocytes, and promote angiogenesis in the ischemic heart tissue.

BPC 157 has also been investigated for its potential to treat pulmonary hypertension, a condition characterized by high blood pressure in the arteries of the lungs. In animal models of pulmonary hypertension, BPC 157 treatment reduced pulmonary artery pressure, improved right ventricular function, and reduced vascular remodeling. These effects are attributed to the peptide’s ability to promote vasodilation, reduce inflammation, and inhibit the proliferation of smooth muscle cells in the pulmonary arteries.

Furthermore, BPC 157 has shown promise in preventing and treating blood clots (thrombosis). Research indicates that BPC 157 can modulate the coagulation cascade and promote fibrinolysis (the breakdown of blood clots). In animal models of deep vein thrombosis, BPC 157 treatment reduced thrombus weight and promoted clot resolution without significantly increasing bleeding risk.

4. Neurological Repair and Neuroprotection

BPC 157 has emerged as a promising research compound in the field of neuroscience due to its potential neuroprotective and neuroregenerative properties. The peptide has been shown to cross the blood-brain barrier and exert direct effects on the central nervous system.

In animal models of traumatic brain injury (TBI), BPC 157 treatment reduced brain edema, preserved neuronal integrity, and improved functional outcomes. The peptide’s neuroprotective effects are attributed to its ability to reduce oxidative stress, inhibit neuroinflammation, and prevent neuronal apoptosis.

BPC 157 has also been studied for its potential to treat spinal cord injuries. In animal models of spinal cord contusion, BPC 157 treatment promoted axonal regeneration, reduced glial scar formation, and improved locomotor function. The peptide’s ability to create a permissive environment for nerve regeneration makes it a promising candidate for further investigation in spinal cord injury research.

Additionally, BPC 157 has shown potential in treating peripheral nerve injuries. In animal models of sciatic nerve injury, BPC 157 treatment accelerated nerve regeneration, improved muscle reinnervation, and enhanced functional recovery. The peptide promotes the proliferation of Schwann cells, which are essential for nerve regeneration, and stimulates the expression of neurotrophic factors such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF).

Preliminary research also suggests that BPC 157 may have potential in treating neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease. In animal models of Parkinson’s disease, BPC 157 treatment protected dopaminergic neurons from degeneration and improved motor function. Similarly, in models of Alzheimer’s disease, BPC 157 reduced amyloid-beta plaque formation and improved cognitive function.

5. Wound Healing and Skin Regeneration

BPC 157 has been extensively studied for its wound healing properties, with research demonstrating its effectiveness in promoting the healing of various types of wounds, including surgical incisions, burns, and diabetic ulcers.

In animal models of surgical wounds, BPC 157 treatment accelerated wound closure, increased tensile strength, and improved collagen deposition. The peptide’s ability to promote angiogenesis, fibroblast proliferation, and collagen synthesis contributes to its wound-healing effects.

For burn injuries, BPC 157 has shown promise in promoting the healing of partial-thickness and full-thickness burns. In animal models of thermal injury, BPC 157 treatment reduced inflammation, promoted re-epithelialization, and improved the quality of healed skin. The peptide also reduced scar formation, resulting in more aesthetically pleasing and functional healed tissue.

Diabetic wounds are particularly challenging to heal due to impaired circulation, reduced growth factor production, and chronic inflammation. BPC 157 has shown significant potential in treating diabetic ulcers by addressing these underlying issues. In animal models of diabetic wounds, BPC 157 treatment accelerated wound closure, improved angiogenesis, and restored normal growth factor expression. The peptide’s ability to improve circulation and reduce inflammation makes it particularly effective in the diabetic wound environment.

6. Liver and Organ Protection

BPC 157 has demonstrated protective effects on various organs, including the liver, kidneys, and lungs. In animal models of liver injury induced by toxins such as carbon tetrachloride (CCl4) or acetaminophen, BPC 157 treatment reduced liver damage, preserved liver function, and promoted liver regeneration.

The peptide’s hepatoprotective effects are attributed to its ability to reduce oxidative stress, inhibit inflammation, and promote the proliferation of hepatocytes (liver cells). BPC 157 has also shown potential in treating liver fibrosis by inhibiting the activation of hepatic stellate cells, which are responsible for excessive collagen deposition in fibrotic liver disease.

In models of acute kidney injury, BPC 157 treatment reduced renal damage, preserved kidney function, and promoted tubular regeneration. The peptide’s protective effects are attributed to its antioxidant and anti-inflammatory properties, as well as its ability to promote the proliferation of renal tubular cells.

BPC 157 has also shown protective effects in models of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). In animal models of LPS-induced lung injury, BPC 157 treatment reduced pulmonary inflammation, decreased lung edema, and improved oxygenation. The peptide’s ability to reduce inflammation and promote tissue repair makes it a promising candidate for further investigation in respiratory disease research.

Product Specifications

Product Name	BPC 157
Sequence	Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula	C62H98N16O22
Molecular Weight	1419.5 g/mol
Purity	≥99%
Appearance	White lyophilized powder
Solubility	Soluble in water and sterile saline
Storage	Store at -20°C upon receipt. After reconstitution, store at 2-8°C for up to 30 days.
Available Sizes	5mg, 10mg
Quality Control	HPLC, Mass Spectrometry, COA provided

Reconstitution and Handling Guidelines

Proper reconstitution and handling are essential for maintaining the stability and efficacy of BPC 157. Follow these guidelines carefully to ensure optimal results in your research.

Reconstitution Procedure:

1. Allow the vial to reach room temperature before opening (approximately 15-20 minutes).
2. Wipe the rubber stopper with an alcohol swab and allow it to dry.
3. Using a sterile syringe, inject the appropriate volume of bacteriostatic water or sterile saline into the vial. For a 5mg vial, add 2.5mL of solvent to achieve a concentration of 2mg/mL. For a 10mg vial, add 5mL of solvent for a 2mg/mL concentration.
4. Gently swirl the vial until the powder is completely dissolved. Do not shake vigorously, as this can denature the peptide.
5. Once fully dissolved, the solution should be clear and colorless. If you notice any particles or discoloration, do not use the solution.

Storage After Reconstitution:

• Store reconstituted BPC 157 in a refrigerator at 2-8°C (36-46°F).
• When stored properly, reconstituted BPC 157 remains stable for up to 30 days.
• For long-term storage (up to 6 months), aliquot the solution into individual doses and store at -20°C. Avoid repeated freeze-thaw cycles, as this can degrade the peptide.
• Do not store reconstituted peptide in direct sunlight or at room temperature for extended periods.

Handling Precautions:

• Always wear gloves and use sterile technique when handling BPC 157.
• Use only sterile syringes and needles for reconstitution and administration.
• Do not mix BPC 157 with other peptides or compounds in the same vial unless you have verified compatibility.
• If you are using BPC 157 for in vitro studies, dilute it to the desired concentration using appropriate buffer solutions.

Frequently Asked Questions (FAQ)

Q1: What is BPC 157 and where does it come from?

A: BPC 157 (Body Protection Compound 157) is a synthetic 15-amino-acid peptide derived from a protective protein found in human gastric juice. The original protein was discovered in the 1990s by researchers investigating the protective properties of gastric juice. They identified that a specific 15-amino-acid fragment was responsible for most of the protein’s healing effects. This fragment was synthesized and named BPC 157. It is important to note that BPC 157 is a synthetic compound and is not extracted from human or animal sources.

Q2: Is BPC 157 legal for research purposes?

A: Yes, BPC 157 is legal for research purposes in most countries, including the United States, when purchased from reputable suppliers and used strictly for laboratory research. It is classified as a research chemical and is not approved for human consumption or therapeutic use by regulatory agencies such as the FDA. Researchers must ensure that their use of BPC 157 complies with all applicable local, state, and federal regulations. At Hanpro Peptides, we sell BPC 157 exclusively for research purposes, and all purchasers must agree to use the product only for legitimate scientific research.

Q3: What is the recommended dosage for BPC 157 in research studies?

A: The optimal dosage of BPC 157 varies depending on the specific research application, animal model, and route of administration. In preclinical studies, dosages have ranged from 10 mcg/kg to 1000 mcg/kg body weight, depending on the study design. For in vitro studies, concentrations typically range from 10 nM to 100 μM. It is important to note that these are research dosages and should not be interpreted as recommendations for human use. Researchers should consult published literature and conduct dose-response studies to determine the optimal dosage for their specific research application. Always follow institutional guidelines and ethical protocols when conducting research with peptides.

Q4: What are the most common routes of administration for BPC 157 in research?

A: In preclinical research, BPC 157 has been administered through various routes, including: (1) Subcutaneous injection – the most common route, allowing for sustained release and systemic distribution; (2) Intraperitoneal injection – commonly used in rodent studies for rapid systemic absorption; (3) Intravenous injection – used when immediate systemic effects are desired; (4) Topical application – used for wound healing and skin regeneration studies; (5) Oral administration – investigated for gastrointestinal applications, though bioavailability may be lower; (6) Local injection at the injury site – used for musculoskeletal injury studies to maximize local concentration. The choice of administration route depends on the research objectives, target tissue, and animal model being used.

Q5: Are there any known side effects or safety concerns with BPC 157?

A: BPC 157 has demonstrated an excellent safety profile in preclinical studies, with no significant adverse effects reported even at dosages many times higher than those typically used in research. The peptide has been shown to have low toxicity and does not appear to have significant effects on blood pressure, heart rate, or other vital signs at therapeutic dosages. However, as with any research compound, there are some important safety considerations: (1) BPC 157 is not approved for human use, and its long-term safety in humans has not been established; (2) Some studies have suggested that BPC 157 may have mild immunomodulatory effects, which should be considered in immunology research; (3) The peptide may interact with certain medications, particularly anticoagulants and antiplatelet drugs, due to its effects on blood clotting; (4) As with any injectable product, there is a risk of local reaction at the injection site, including redness, swelling, or pain. Researchers should always follow proper safety protocols and consult institutional safety guidelines when working with BPC 157.

Q6: How does BPC 157 compare to other healing peptides like TB-500?

A: BPC 157 and TB-500 (Thymosin Beta-4) are both peptides that have been extensively studied for their healing properties, but they work through different mechanisms and have distinct profiles. BPC 157 primarily works by promoting angiogenesis, modulating growth factors, and reducing inflammation. It is particularly effective for gastrointestinal healing, musculoskeletal repair, and organ protection. TB-500, on the other hand, works by promoting cell migration and differentiation, and is particularly known for its effects on connective tissue healing and flexibility. Some researchers use BPC 157 and TB-500 in combination, as they may have synergistic effects. However, it is important to note that combination therapy has not been extensively studied, and researchers should exercise caution when combining peptides. At Hanpro Peptides, we offer both BPC 157 and TB-500, as well as a combination product (BPC + TB), for research purposes.

Q7: What is the shelf life of BPC 157, and how should it be stored?

A: When stored properly, lyophilized (freeze-dried) BPC 157 has a shelf life of up to 2 years from the date of manufacture when stored at -20°C in a freezer. It is important to keep the peptide in its original sealed vial and protect it from light, moisture, and temperature fluctuations. After reconstitution, BPC 157 should be stored in a refrigerator at 2-8°C and used within 30 days. For longer storage of reconstituted peptide (up to 6 months), it is recommended to aliquot the solution into individual doses and store at -20°C. However, repeated freeze-thaw cycles should be avoided, as they can degrade the peptide over time. Always check the product’s expiration date and Certificate of Analysis (COA) for specific storage recommendations. At Hanpro Peptides, all our products are shipped with cold packs to maintain stability during transit, and each vial comes with a detailed COA specifying the manufacture date, expiration date, and purity level.

Related Products for Research

For researchers investigating tissue repair and regeneration, we recommend exploring these related peptides:

• TB-500 (Thymosin Beta-4 Acetate) – A peptide known for promoting cell migration, connective tissue healing, and flexibility. Often studied in combination with BPC 157 for synergistic effects on wound healing and tissue repair.
• BPC + TB Combination – A pre-mixed combination of BPC 157 and TB-500, designed for researchers investigating the synergistic effects of these two healing peptides. Available in convenient combination vials.
• GHK-Cu (Copper Peptide) – A naturally occurring peptide complex with copper, known for its wound healing, anti-inflammatory, and tissue regeneration properties. Particularly studied for skin and hair follicle regeneration.
• KPV (Lysine-Proline-Valine) – A tripeptide derived from alpha-MSH, with potent anti-inflammatory and antimicrobial properties. Studied for inflammatory bowel disease, skin conditions, and wound healing.
• Ipamorelin – A growth hormone secretagogue that stimulates the release of growth hormone, supporting tissue repair, muscle growth, and recovery. Often used in combination with healing peptides for enhanced regenerative effects.
• CJC-1295 Without DAC – A growth hormone-releasing hormone (GHRH) analog that increases growth hormone and IGF-1 levels, supporting tissue repair and recovery. Frequently studied in combination with Ipamorelin.

Quality Assurance at Hanpro Peptides

At Hanpro Peptides, we are committed to providing researchers with the highest quality peptides available. Our BPC 157 is manufactured in state-of-the-art facilities using solid-phase peptide synthesis (SPPS) technology, ensuring consistent quality and purity batch after batch.

Our Quality Control Process Includes:

• High-Performance Liquid Chromatography (HPLC): Every batch is analyzed by HPLC to verify purity ≥99%. This ensures that our products are free from impurities and contaminants that could affect research results.
• Mass Spectrometry (MS): Mass spectrometry is used to confirm the molecular weight and identity of each peptide, ensuring that the product matches the expected amino acid sequence.
• Certificate of Analysis (COA): Every product comes with a detailed COA that includes the batch number, manufacture date, expiration date, purity level, and test results. Researchers can use this information to verify product quality and document their research materials.
• Microbiological Testing: Our products undergo rigorous microbiological testing to ensure they are free from bacteria, fungi, and other microorganisms.
• Endotoxin Testing: For peptides intended for in vivo studies, we conduct endotoxin testing to ensure that levels are within acceptable limits for research use.

We also offer custom peptide synthesis services for researchers who require specific sequences, modifications, or formulations. Our team of experienced chemists can synthesize peptides ranging from simple dipeptides to complex 50+ amino acid sequences with various modifications, including acetylation, amidation, phosphorylation, and fluorescent labeling.

Disclaimer

Important Notice: All products sold by Hanpro Peptides are intended for laboratory research purposes only. They are not intended for human consumption, diagnostic use, or therapeutic application. BPC 157 has not been approved by the FDA or any other regulatory agency for human use, and its safety and efficacy in humans have not been established.

Researchers are responsible for ensuring that their use of our products complies with all applicable local, state, and federal regulations, as well as institutional guidelines and ethical protocols. Our products should only be used by qualified researchers in properly equipped laboratory settings.

The information provided in this product description is for educational and informational purposes only and is based on published scientific literature. It does not constitute medical advice, and we make no claims regarding the therapeutic effects or safety of our products for human use. Any references to potential therapeutic applications are based on preclinical research and are not intended to suggest that these products are safe or effective for human consumption.

By purchasing and using our products, you acknowledge and agree that you are a qualified researcher, that you will use our products only for legitimate scientific research, and that you assume all responsibility for ensuring compliance with applicable regulations and ethical guidelines.

If you have any questions about our products, quality control processes, or custom synthesis services, please contact our customer support team. We are committed to providing researchers with the highest quality products and exceptional customer service to support your important research endeavors.